Last updated at 21 Feb 2025 05:33 AM
Director
DIN: 01544061
Satya Kameswari Vakkalanka is currently associated with 5 companies in various capacities such as Director and Designated Partner. They serve as a Director at ZANTHERA PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01544061.Satya Kameswari Vakkalanka is currently involved in 2 different roles. Their most recent position is with ZAIAN REMEDIES LLP as a Designated Partner. The first company Satya Kameswari Vakkalanka was appointed to as a director was ZANTHERA PHARMACEUTICALS PRIVATE LIMITED. Satya Kameswari Vakkalanka is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Satya Kameswari Vakkalanka is currently associated with 5 companies in various capacities such as Director and Designated Partner. They serve as a Director at ZANTHERA PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01544061.Satya Kameswari Vakkalanka is currently involved in 2 different roles. Their most recent position is with ZAIAN REMEDIES LLP as a Designated Partner. The first company Satya Kameswari Vakkalanka was appointed to as a director was ZANTHERA PHARMACEUTICALS PRIVATE LIMITED. Satya Kameswari Vakkalanka is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
5
Female
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (2)
Past Companies (0)
3y 8m 1y 10m Interval
Company Name | Designation | Date of Appointment |
---|---|---|
ZANTHERA PHARMACEUTICALS PRIVATE LIMITED | Director | 08-Aug-2007 |
SIRAK PHARMACEUTICALS PRIVATE LIMITED | Director | 08-Jan-2008 |
INCOZEN THERAPEUTICS PRIVATE LIMITED | Director | 30-Aug-2008 |